Brief: Cereno Scientific Says Co And Abbott Enter Collaboration For Use Of Cutting-Edge Monitor Device In Upcoming Phase II Study With Cs1
Aug 11 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC AND ABBOTT ENTER COLLABORATION FOR USE
OF
CUTTING-EDGE MONITOR DEVICE IN UPCOMING PHASE II STUDY WITH CS1
* CERENO SCIENTIFIC AB - STUDY IS PLANNED TO BE INITIATED IN
SEPTEMBER 2021 FOLLOWING ACCEPTANCE FROM U.S. FDA OF
INVESTIGATIONAL NEW DRUG APPLICATION
Source text for Eikon: ID:nWkr8knQ1d
Further company coverage: CRNOSb.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln